CEBPB-AS1

Across TCGA pan-cancer cohorts, CEBPB-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CEBPB-AS1 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher CEBPB-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CEBPB-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and SKCM show a favorable association.

PAAD, SKCM, and UCEC are the cancer types where CEBPB-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Quartile	All	0.404	0.165	<.001	59	view →
SKCM	DFS	Quartile	All	0.708	0.474	<.001	42	view →
UCEC	DFS	Median	All	0.797	0.875	.004	28	view →
UVM	DFS	Median	III,IV	0.323	0.867	.018	25	view →
ACC	DFS	Tertile	All	0.494	0.905	.001	24	view →
LUSC	OS	Tertile	III,IV	0.199	0.503	.012	17	view →
COAD	OS	Median	IV	0.641	0.431	.026	11	view →
UCS	DFS	Median	IV	0.885	0.440	.015	8	view →
READ	DFS	Tertile	All	0.670	0.926	.015	8	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	7	view →
MESO	DFS	Tertile	All	0.349	0.648	.034	6	view →
HNSC	OS	Median	IV	0.765	0.647	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

CEBPB-AS1–PAAD (DFS)

Open the PAAD breakdown →